Mesoblast Limited (MEOBF) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of $1.55B. The enterprise value is $713.46M.

Mesoblast Limited has 1,277,782,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast Limited’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -13.77%.

The current PE Ratio of Mesoblast Limited is -7.47. Mesoblast Limited’s PEG ratio is -0.04.

In the last 12 months, Mesoblast Limited had revenue of 5.90M and earned -87.96M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -20.66M and capital expenditures -233.00K, giving a free cash flow of -21.07M billion.

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

Mesoblast Limited as a current ratio of 1.18, with Debt / Equity ratio of 16.90%

In the past 12 months, Mesoblast Limited has paid 191.00K in taxes.

Mesoblast Limited EV to EBITDA ratio is -12.72, with an EV/FCF ratio of -14.62.

Mesoblast Limited has $38.03M in cash and marketable securities with $126.11M in debt, giving a net cash position of $88.08M billion.

Gross margin is -349.55%, with operating margin of -1425.74%, and net profit margin of -1490.27%.

The average price target for Mesoblast Limited is $2.21, which is 11.43% higher than the current price. The consensus rating is Moderate Buy